Rosetta Genomics (ROSG) Announces Sale of PersonalizeDx Business to Pragmin Prognosis for $2.875M
Tweet Send to a Friend
Rosetta Genomics Ltd. (NASDAQ: ROSG) announces that it has entered into a definitive agreement to sell all of its ownership ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE